EMA To Get Tough On Companies That Repeatedly Delay New Marketing Applications

Disappointed that its earlier initiative to improve the predictability of planned marketing authorization applications has failed to have an impact, the European Medicines Agency is discussing introducing more active measures as passive ones are not working.